During the past decade, Nakamoto Internal Medicine Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nakamoto Internal Medicine Clinic" are "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Endocrine System Diseases" (1 trials), "Glucose Metabolism Disorders" (1 trials) and "Hypoglycemic Agents" (1 trials). Many other conditions were trialed in "Nakamoto Internal Medicine Clinic" in a lesser frequency.

Most popular intervention types in "Nakamoto Internal Medicine Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alpha-Glucosidase Inhibitors (α-GI)" (1 trials), "Biguanide (BG)" (1 trials), "Dulaglutide" (1 trials), "Glinides (GLN)" (1 trials) and "Insulin Degludec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nakamoto Internal Medicine Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nakamoto Internal Medicine Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Nakamoto Internal Medicine Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nakamoto Internal Medicine Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".